http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110755373-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 |
| filingDate | 2019-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110755373-B |
| titleOfInvention | Fasudil hydrochloride injection pharmaceutical composition and preparation method thereof |
| abstract | The invention belongs to the technical field of biological medicines, and particularly relates to a fasudil hydrochloride injection pharmaceutical composition and a preparation method thereof. The fasudil hydrochloride injection pharmaceutical composition comprises the following raw materials in parts by weight: 35-50 parts of fasudil hydrochloride; 1-10 parts of nicotinamide; 1-10 parts of phenylalanine; 5-20 parts of N-acetylcysteine; 10-20 parts of sodium chloride; 1000-3000 parts of water for injection; the pH of the injection is adjusted to 5.7-6.3 by using a pharmaceutically acceptable pH regulator. The hydrochloric acid faxsul injection pharmaceutical composition is colorless and clear, does not contain visible impurities, is stable to light under the condition that the pH value is 5.7-6.3, has low impurity content and controllable quality, and improves the medication safety. |
| priorityDate | 2019-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.